Note: The job is a remote job and is open to candidates in USA. Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company focused on precision medicine through targeted radiation. The Director, Product Marketing – Upstream Late-Stage PSMA is responsible for shaping the commercial vision and lifecycle strategy for Telix's late-stage PSMA imaging portfolio, guiding cross-functional teams and ensuring optimal product positioning.
Responsibilities
- Lead the development, refinement, and execution of commercial and lifecycle strategies for Illuccix®, Gozellix®, and late-stage PSMA programs
- Serve as the primary commercial thought leader guiding market evolution, competitive positioning, and long-range franchise strategy. Working closely with the Global Commercial PSMA team
- Build and steward a deep understanding of customer segments—including imaging centers, urology networks, and integrated specialty groups—to shape portfolio and pipeline decisions
- Partner with regional leaders and medical counterparts to proactively identify evidence needs and influence data-generation priorities
- Own the development and executive-level delivery of business cases, TAM/SAM analyses, value assessments, and lifecycle scenario modeling
- Collaborate with Commercial Strategy & Operations to pressure-test, align, and update late-stage forecasts and financial assumptions
- Anticipate market trends, competitive shifts, and adoption patterns to inform PMC submissions and investment decisions
- Convert complex commercial analyses into clear, strategic recommendations for regional leadership teams
- Act as the senior commercial partner to GDLs, ensuring late-stage development aligns with market needs, differentiation strategy, and launch readiness
- Lead cross-functional governance with Medical Affairs, Regulatory, Market Access, and Marketing Operations to ensure regional alignment across lifecycle activities
- Oversee commercial contributions to Launch Readiness Reviews (LRRs) and drive post-launch optimization frameworks
- Ensure a seamless upstream-to-downstream transition by aligning GTM strategy, messaging, and operational scaling across regions
- Oversee the synthesis of competitive intelligence, including clinical progress, regulatory events, launch timing, messaging, and technology advances
- Provide strategic insights that shape brand positioning, lifecycle prioritization, and risk mitigation plans
- Monitor policy, reimbursement, and market access shifts to anticipate barriers and opportunities for PSMA imaging adoption
- Lead high-impact strategic initiatives such as lifecycle indication launches, expansion projects, and multi-regional alignment activities
- Drive execution excellence by setting timelines, governance structures, and communication standards for cross-functional teams
- Present strategic updates, insights, and recommendations to executive leadership and participate in PMC and portfolio governance forums
Skills
- Bachelor's degree in Marketing, Business, or Life Sciences
- 8–12+ years of experience in pharmaceutical, biotech, molecular imaging, medical device or diagnostics marketing, ideally in oncology or urology
- Proven experience leading upstream product strategy, lifecycle management, or commercial planning for late-stage assets
- Strong ability to synthesize scientific, clinical, communicate commercial insights into strategic decision-making
- Demonstrated success influencing cross-functional teams in complex, matrixed environments
- Strong financial and analytical acumen, with experience developing sophisticated forecasts and investment cases
- Exceptional communication, executive presentation, and stakeholder leadership skills
- Advanced project leadership and organizational capabilities
- MBA or advanced degree strongly preferred
Benefits
- Competitive salaries
- Annual performance-based bonuses
- An equity-based incentive program
- Generous vacation
- Paid wellness days
- Support for learning and development
- Hybrid and remote employees located all around the world
Company Overview